Follow our news on LinkedIn

Learn more
Oncodesign Precision Medicine Stand with Ukraine

Follow our news on LinkedIn

Learn more
  • Our pipeline
    • Partnering
  • Our innovation technologies
    • OncoSNIPER
    • Nanocyclix®
    • PROMETHE®
  • Investors
    • Regulated information [FR]
    • Press Release
    • General Meetings [FR]
  • About us
    • Latest news
    • Our history
    • Management
    • Our HR policy
    • Our CSR approach
    • FederAidd
  • Contact us
  • Français
  • English

Posts

  • You are currently browsing the archives for the Financial category.

  • Pages

    • About us
      • Careers
      • FederAidd
      • News
      • Our CSR approach
      • Our history
    • Contact us
    • Home
    • Investors
      • Investor Day 2023
      • Regulated information [FR]
    • Legal notice
    • Our innovation technologies
      • Nanocyclix
      • OncoSNIPER
      • PROMETHE ®
    • Our pipeline
      • Partnering
    • Personal data policy
    • Press Release
    • Thank you for signing up to our newsletter
    • Thank you for your message.

  • Archives

    • October 2023
    • September 2023
    • May 2023
    • April 2023
    • February 2023
    • December 2022
    • October 2022
    • September 2022
    • July 2022
    • June 2022
    • March 2022
    • February 2022
    • January 2022
    • October 2021
    • June 2021
    • May 2021
    • September 2020
    • October 2019

  • Categories

    • Financial (7)
    • News (14)
    • Poster (3)
    • Press Release (17)
    • Scientific paper (4)
    • Uncategorized (1)
Oncodesign Precision Medicine
  • Our innovation technologies
    • OncoSNIPER
    • Nanocyclix
    • PROMETHE
  • Our pipeline
  • Latest News
  • About us
  • Investors
  • Contact us

Newsletter

  • Legal notice
  • Personal data policy